Literature DB >> 7492484

Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients.

N L Reinsmoen1, C McSherry, B Chavers, M I Hertz, A J Matas.   

Abstract

Our previous studies indicate donor antigen-specific hyporeactivity is a useful marker for identifying solid organ transplant recipients at low risk for immunological complications; the hyporeactive subgroup experiences a lower incidence of chronic rejection. One purpose of the current study was to determine whether hyporeactivity could be identified in pediatric kidney recipients and whether it correlated with improved graft outcome. Of 18 pediatric kidney recipients tested, 6 (33%) had developed donor antigen-specific hyporeactivity. All 18 experienced good graft outcome. Second, we determined whether donor antigen-specific hyporeactivity correlates with peripheral blood microchimerism and outcome in adult kidney recipients. Our previous studies of lung recipients demonstrated development of obliterative bronchiolitis in recipients with microchimerism who remain responsive, but not in recipients who had become hyporesponsive to donor antigen. Preliminary results in our current study of 23 adult kidney recipients indicate microchimerism for 6 (26%): 4 hyporesponsive and 2 responsive to donor antigen. Microchimerism was not detected for 17 recipients: 6 hyporesponsive and 11 responsive to donor antigen. One hyporesponsive/chimeric patient and 4 recipients negative for both parameters have been diagnosed with biopsy-proven chronic rejection. In summary, both hyporeactivity and chimerism are found at a higher frequency in lung than kidney recipients. Unlike lung recipients, not all hyporesponsive kidney recipients had peripheral blood chimerism. Additional numbers are needed to determine if microchimerism correlates with donor antigen-specific hyporeactivity or graft outcome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492484     DOI: 10.1007/bf00867681

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  27 in total

Review 1.  Cell migration, chimerism, and graft acceptance.

Authors:  T E Starzl; A J Demetris; N Murase; S Ildstad; C Ricordi; M Trucco
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  Acquired donor-specific hyporesponsiveness in long-term kidney allograft recipients.

Authors:  N L Reinsmoen; A Matas; D Kaufman; D Sutherland; J S Najarian; F H Bach
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease.

Authors:  T E Starzl; A J Demetris; M Trucco; C Ricordi; S Ildstad; P I Terasaki; N Murase; R S Kendall; M Kocova; W A Rudert
Journal:  N Engl J Med       Date:  1993-03-18       Impact factor: 91.245

4.  Clinical and immunological studies of cadaveric renal transplant recipients given total-lymphoid irradiation and maintained on low-dose prednisone.

Authors:  V Saper; D Chow; E D Engleman; R T Hoppe; B Levin; G Collins; S Strober
Journal:  Transplantation       Date:  1988-03       Impact factor: 4.939

5.  Evidence for suppressor cells and reduced CML induction by the donor in transplant patients.

Authors:  E M Liburd; V Pazderka; T Kovithavongs; J B Dossetor
Journal:  Transplant Proc       Date:  1978-09       Impact factor: 1.066

6.  Risk factors for chronic rejection in renal allograft recipients.

Authors:  P S Almond; A Matas; K Gillingham; D L Dunn; W D Payne; P Gores; R Gruessner; J S Najarian
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

7.  Evidence of donor-specific cellular suppressor activity in donor-specific cell-mediated lympholysis unresponsiveness in renal transplant patients.

Authors:  L Wramner; M Olausson; T Söderström; L Lindholm; L Rydberg; H Brynger
Journal:  Transplantation       Date:  1987-09       Impact factor: 4.939

8.  Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity.

Authors:  N L Reinsmoen; R M Bolman; K Savik; K Butters; A J Matas; M I Hertz
Journal:  J Heart Lung Transplant       Date:  1994 Jan-Feb       Impact factor: 10.247

9.  Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation.

Authors:  T E Starzl; A J Demetris; M Trucco; A Zeevi; H Ramos; P Terasaki; W A Rudert; M Kocova; C Ricordi; S Ildstad
Journal:  Transplantation       Date:  1993-06       Impact factor: 4.939

10.  Renal transplant patients monitored by the cell-mediated lympholysis assay. Evaluation of its clinical value.

Authors:  E Goulmy; T Stijnen; A F Groenewoud; G G Persijn; E Blokland; J Pool; L C Paul; J J van Rood
Journal:  Transplantation       Date:  1989-10       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.